VXX News 40.00 05/05/2014 05:45:39 VIX Short-Term Futures ETN

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
VIX Short-Term Futures ETN Ipath (VXX) 40.00 $VXX

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Rebound After Yesterday's Selloff of 1.83%
Comtex SmarTrend(R) - Tue Apr 29, 3:39PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.15 to a high of $40.91. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $40.72 on volume of 25.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Falls 1.85% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 21, 3:46PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.85 to a high of $41.73. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $41.62 on volume of 21.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.85%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Apr 21, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.85 to a high of $41.73. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $41.62 on volume of 21.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Falls 3.57% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Apr 16, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.28 to a high of $43.71. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $43.33 on volume of 33.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound after Yesterday's 3.57% Sell Off
Comtex SmarTrend(R) - Wed Apr 16, 3:44PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.28 to a high of $43.71. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $43.33 on volume of 33.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Rally of 6.00% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Apr 10, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.96 to a high of $43.60. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of $43.41 on volume of 47.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 Signs the Dow's Drop Is Just a Dip
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 07, 8:03PM CDT
The Dow Jones Industrials fell 166 points Monday, following up on Friday's similar losses and getting many investors fearful about the future of stocks. With the popular "sell in May" indicator just a few weeks away from triggering its seasonal...

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Pullback After Yesterday's Rally of 2.07%
Comtex SmarTrend(R) - Fri Apr 04, 3:43PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.25 to a high of $42.36. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $42.06 on volume of 48.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Don't Let These ETFs Fool You - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Tue Apr 01, 10:45AM CDT
Most ETFs are simple and transparent but investors need to be aware of a few potential pitfalls with some ETFs.

After Yesterday's Decline of 3.21%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Mar 31, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.11 to a high of $43.15. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $43.30 on volume of 28.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Dow Correction: Why You Shouldn't Panic Over Market Volatility
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 26, 3:30PM CDT
On Wednesday, the Dow Jones Industrials lost almost 100 points, finishing near the day's lows as investors worried about a variety of factors that could hurt the market's future prospects. That range of issues runs from the threat of war in...

'Fast Money' Recap: Opportunities in Technology
at The Street - Wed Mar 26, 4:00AM CDT
The trading panel discussed some familar names -- IBM, Hewlett-Packard and Qualcomm.

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 3.94% Yesterday
Comtex SmarTrend(R) - Tue Mar 18, 3:44PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $43.31 to a high of $44.41. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $43.62 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

The Dow Gets Complacent Again, but is the Russia-Ukraine Conflict Really Over?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Mar 17, 11:30AM CDT
After the weekend's referendum on Crimea's rejoining Russia went much as expected, but without any huge escalation in the conflict, investors celebrated by sending the Dow Jones Industrials up nearly 190 points, or 1.2%, as of 12:30 p.m. EDT. At...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 24

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
Western Microsurgical Expands Through Strategic Acquisitions

Updated Category News Views 95

Western Microsurgical's Bold Moves Western Microsurgical (WMS) is out here making waves, pulling off some serious strategic plays with the acquisitions of Q Surgical and Proficient Surgical. Now, this ain't some fly-by-night decision—this is about securing territory and leveling up their game in surgical microscopes and operating room supplies. With a footprint that'll...

Continue Reading
Local Expertise Key in Navigating Tahoe Real Estate

Updated Category News Views 105

Diving Into Tahoe's Unique Real Estate Scene If you think all real estate markets sing the same tune, take a stroll through South Lake Tahoe's offerings, and you'll find yourself singing a different song. Buying property in this neck of the woods requires more than a keen eye for granite countertops or a Zillow addiction. It demands a local guide—someone who knows the...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 112

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 147

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Endava Faces Class Action: Investors Eye Their Next Move

Updated Category News Views 52

A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...

Continue Reading
Brinker International Posts Solid Q1 2027 Earnings

Updated Category News Views 15

Strong Earnings Highlight a Winning Streak Brinker International, folks, has done it again. With the latest release of their first quarter fiscal 2027 results, it’s clear they’ve been hitting the right notes, especially at Chili’s. The numbers don't lie—trust me, I've seen my fair share of earnings calls, and this one's got meat on the bones. Let’s break it...

Continue Reading
Corgi Insurance Eyes $100B Auto Market with New Launch

Updated Category News Views 93

Leaping Into a Booming Market Well, it looks like someone lit a fire under Corgi Insurance, and they're ready to chase bigger bones. They’ve just rolled out a product called Corgi Business Auto, signaling quite a bold move into the hefty, nearly $100 billion U.S. commercial auto insurance arena. Now, as an old hand at this game, my ears perk up whenever I see a player...

Continue Reading
Navigating Home Care: What Families Need to Know

Updated Category News Views 94

Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...

Continue Reading
CPSC's Battle Against Dangerous Imports Intensifies

Updated Category News Views 0

Feldman Sounds Alarm at Bangkok Conference Imagine the chaos if safety took a back seat in our daily lives. Well, that's exactly what's at stake with the influx of dangerous consumer products sailing into our markets. Acting Chairman of the U.S. Consumer Product Safety Commission (CPSC), Peter A. Feldman, gave a no-holds-barred speech on this matter at the INTERPOL...

Continue Reading

Top 5 Most Recently Viewed Articles

BellRing Brands (NYSE: BRBR) Faces Investigation Over Fraud Claims

Updated Category News Views 124

BellRing Brands Under Investigation Recently, it has come to light that BellRing Brands, Inc. (NYSE: BRBR) is facing an intense investigation concerning potential securities fraud. This inquiry is spearheaded by the prominent securities law firm Bleichmar Fonti & Auld LLP, which is examining the company for possible violations of federal securities laws. For those who...

Continue Reading
SQAIRZ Unveils New Era in Pickleball Footwear with Zane Navratil

Updated Category News Views 625

Exciting News from SQAIRZ: Zane Navratil Joins the Team SQAIRZ, known for its innovative approach to athletic footwear, is proud to announce the latest addition to its team: Zane Navratil, a celebrated figure in the world of pickleball. As a multiple-time champion, Zane brings a wealth of knowledge and experience to SQAIRZ, playing a key role in the development of the...

Continue Reading
Stem Inc. Welcomes New CTO to Propel AI Innovation Forward

Updated Category News Views 108

Stem Inc. Appoints Dr. Albert Hofeldt as New CTO SAN FRANCISCO - Stem Inc. (NYSE: STEM), a leading company in AI-enabled clean energy software and services, has elevated Dr. Albert Hofeldt to the role of Chief Technology Officer (CTO). This significant move aims to strengthen the company's technological front through innovative software solutions. Dr. Hofeldt's Role in...

Continue Reading
Discover October’s Top Investment Picks for Savvy Investors

Updated Category News Views 106

Understanding the MarketRank Tool for Stock Insights For investors seeking valuable insights, tools like the MarketRank™ feature by MarketBeat are indispensable. This tool compiles data for over 1.5 million stock listings globally, categorizing them across eight distinct areas. Its scoring system ranks stocks from one to five, with a Five Star rating highlighting those...

Continue Reading
Equinox Gold Earnings on Deck: EPS Insights and Trader Vibes

Updated Category News Views 116

Equinox Gold (AMEX:EQX) is set to drop its quarterly earnings on February 18, 2026, and you better believe traders are locked in. The buzz around this release isn’t just idle chatter; it's the kind that moves markets. Analysts are pegging the earnings per share (EPS) at a neat $0.21. Yeah, you heard right—$0.21 could make or break sentiment here. EPS Expectations:...

Continue Reading